These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8112367)

  • 21. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.
    Hochster H; Dieterich D; Bozzette S; Reichman RC; Connor JD; Liebes L; Sonke RL; Spector SA; Valentine F; Pettinelli C
    Ann Intern Med; 1990 Jul; 113(2):111-7. PubMed ID: 2163228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.
    Connolly KJ; Allan JD; Fitch H; Jackson-Pope L; McLaren C; Canetta R; Groopman JE
    Am J Med; 1991 Nov; 91(5):471-8. PubMed ID: 1659189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of zidovudine administered by continuous infusion in children.
    Balis FM; Pizzo PA; Murphy RF; Eddy J; Jarosinski PF; Falloon J; Broder S; Poplack DG
    Ann Intern Med; 1989 Feb; 110(4):279-85. PubMed ID: 2643914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
    Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
    JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and bioavailability of zidovudine in humans.
    Blum MR; Liao SH; Good SS; de Miranda P
    Am J Med; 1988 Aug; 85(2A):189-94. PubMed ID: 3165603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex.
    Horton CM; Dudley MN; Kaul S; Mayer KH; Squires K; Dunkle L; Anderson R
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2309-15. PubMed ID: 8619587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease.
    Fletcher CV; Rhame FS; Beatty CC; Simpson M; Balfour HH
    Pharmacotherapy; 1992; 12(6):429-34. PubMed ID: 1492005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.
    Ruhnke M; Bauer FE; Seifert M; Trautmann M; Hille H; Koeppe P
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2153-8. PubMed ID: 8257138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.
    Chave JP; Munafo A; Chatton JY; Dayer P; Glauser MP; Biollaz J
    Antimicrob Agents Chemother; 1992 May; 36(5):1013-8. PubMed ID: 1324635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease.
    Kapembwa MS; Fleming SC; Orr M; Wells C; Bland M; Back D; Griffin GE
    AIDS; 1996 Nov; 10(13):1509-14. PubMed ID: 8931785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.
    Dournon E; Matheron S; Rozenbaum W; Gharakhanian S; Michon C; Girard PM; Perronne C; Salmon D; De Truchis P; Leport C
    Lancet; 1988 Dec; 2(8623):1297-302. PubMed ID: 2904016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053).
    Aweeka FT; Gambertoglio JG; van der Horst C; Raasch R; Jacobson MA
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1773-8. PubMed ID: 1416864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption of zidovudine in patients with diarrhoea.
    Zorza G; Beaugerie L; Taburet AM; Le Quintrec Y; Singlas E
    Eur J Clin Pharmacol; 1993; 44(5):501-3. PubMed ID: 8359192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of indomethacin and naproxen on zidovudine pharmacokinetics.
    Barry M; Howe J; Back D; Breckenridge A; Brettle R; Mitchell R; Beeching NJ; Nye FJ
    Br J Clin Pharmacol; 1993 Jul; 36(1):82-5. PubMed ID: 8373716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
    Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM
    N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.